Phase I/II study of a peptide-based COVID-19 vaccine to induce T-cell responses against SARS-CoV-2 in cancer patients with B-cell deficiency
J. Heitmann,C. Tandler,M. Marconato,T. Habibzade,S. M. Rittig, C. M. Tegeler,A. Nelde,Y. Maringer, S. Jaeger,M. Denk, M. Richter, M. T. Oezbek,K. H. Wiesmueller, J. Bauer, J. Rieht,M. Wacker, S. Schroeder,S. Hoerber,A. Peter, C. Meisner, I. Fischer,M. W. Loeffler,C. A. Peuker,S. Habringer,T. O. Goetze,E. Jaeger,H. G. Rammensee,H. R. Salih, J. S. Walz ONCOLOGY RESEARCH AND TREATMENT（2022）
AI 理解论文
溯源树
样例
